Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Clinical Trials Related to Membranous Nephropathy
Related studies linked through entity extraction aliases.
Omics of Rituximab-resistance
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
A Study to Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis
- Status
- RECRUITING
- Phase
- PHASE2
Effect of B-cell Depleting Therapies on PLA2R-specific B Cells in Patients With Membranous Nephropathy
- Status
- COMPLETED
- Phase
- NA
Raman Spectroscopy Diagnosis of Kidney Diseases
- Status
- RECRUITING
- Phase
- N/A
IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX)
- Status
- RECRUITING
- Phase
- PHASE3
Circulating Factors in Nephrotic Syndrome
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
An Outcome Analysis of Primary Membranous Nephropathy
- Status
- RECRUITING
- Phase
- N/A
National Registry of Rare Kidney Diseases
- Status
- RECRUITING
- Phase
- N/A
Interferon Alfa Therapy Based on Th17 Profile in Membranous Nephropathy
- Status
- UNKNOWN
- Phase
- PHASE2
Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014)
- Status
- TERMINATED
- Phase
- PHASE2
An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Correlation and Clinical Utility of Urinary Biomarker in Membranous Glomerulonephritis
- Status
- RECRUITING
- Phase
- N/A
Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
- Status
- RECRUITING
- Phase
- N/A
Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN)
- Status
- TERMINATED
- Phase
- PHASE2
Obinutuzumab in Primary MN
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
MOR202 for Refractory MN
- Status
- COMPLETED
- Phase
- PHASE2